@FiercePharma: Teva eyes M&A in Asia. Future generics growth will be centered there, CFO says at #JPM12--Bloomberg. News | Follow @FiercePharma
> Abbott Laboratories ($ABT) isn't in the running to buy Pfizer's ($PFE) nutritionals business, a spokeswoman for the company told Bloomberg. News
> Injectables maker NantWorks plans to spend $85.5 million on a new manufacturing facility at Pfizer's former Exubera manufacturing site in Indiana, creating more than 230 jobs in the process. Report
> The Obama administration is likely to block the proposed $716 million merger between Omnicare and PharMerica, sources tell the New York Post. Story
> India chalked up its first year without a new case of polio, the Gates Foundation said. Item
> Novartis ($NVS) board member Pierre Landolt sold 1.41 million shares in the company, a source told Bilanz. Article
> Leo Pharma introduced a patient education and co-pay discount program for its Taclonex psoriasis-fighting products. Release
> Prescriptions for the narcotic painkiller oxycodone increased 82% from 2007 to 2010 in New York state, a new report found. More
> On the heels of new FDA restrictions on antibiotics in livestock, a global animal health organization called for action against abuse of antibiotics in agriculture. Piece
Biotech News
@FierceBiotech: Geron brings in broker to sell stem cell project. CEO thinks resources of biotech cos. at #JPM12 are 'very finite.' Article | Follow @FierceBiotech
@JohnCFierce: Unusually harsh lead on Dow Jones piece re Scangos and Biogen's "decimated" early pipeline. Is the honeymoon over? News | Follow @JohnCFierce
@RyanMFierce Optimer ($OPTR) COO is leaving antibiotics developer to "pursue other interests." Release | Follow @RyanMFierce
> BioCity Scotland creates a new life sciences incubator at Merck site. Item
> Biogen CEO Scangos aims to patch weak points in pipeline. Report
> Geron brings in broker to sell stem cell project. Story
Manufacturing News
> Interview: M+W on lean plants and carmakers. News
> FDA seeks electronic reporting of drug stability tests. Article
> It's 'T' time for contract manufacturers. Report
Vaccines News
> ImmunoCellular starts Phase II trial of brain cancer vaccine. Item
> As India nears polio eradication, researchers ponder new vaccines. News
> Microtest to manufacture ImmusanT's celiac vaccine. Story
And Finally... Running a marathon or half-marathon doesn't boost the risk of suffering a heart attack more than other vigorous exercise does, a New England Journal of Medicine study has found. Report